Basil Al-Sabeq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Basil Al-Sabeq has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Faisal Nabi
Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas
5 shared publications- Faisal Nabi
Aligarh Muslim University
2 shared publications - Scott Patrick Heximer
Toronto, Ontario
2 shared publications Steven Gu
Department of Physiology, Heart, and Stroke University of Toronto Toronto Ontario Canada
2 shared publicationsAhmed Soliman
Division of Cardiovascular Imaging, Department of Cardiology, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA
1 shared publicationAlex Tam
Department of Physiology, Heart, and Stroke University of Toronto Toronto Ontario Canada
1 shared publication
Latest Publications
- 6 July 2020
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 35 (5) , 445-453
Imaging in mitral stenosis
Purpose of review Mitral stenosis remains clinically relevant in developing countries where rheumatic heart disease is the predominant culprit. In the western world, mitral annular and valvular calcification is an increasingly recognized cause, particularly in an aging population. Echocardiography plays a primary role in imaging mitral stenosis with a growing role for cardiac computed tomography and magnetic resonance imaging. In this review, we aim to revisit mitral stenosis assessment and quantification using multimodality imaging. Recent findings There is an increasing role for advanced cardiac imaging especially in the era of transcatheter mitral valve intervention. Also, when echocardiography is suboptimal or discordant with symptoms, computed tomography can provide anatomical data, whereas magnetic resonance imaging can provide anatomical along with hemodynamic data. Summary Diagnosis of mitral stenosis is crucial as it carries an increased morbidity and mortality risk. Echocardiography is the cornerstone imaging modality with alternative, complementary advanced imaging considered when images are suboptimal.
- 6 July 2020
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 35 (5) , 445-453
Imaging in mitral stenosis
Purpose of review Mitral stenosis remains clinically relevant in developing countries where rheumatic heart disease is the predominant culprit. In the western world, mitral annular and valvular calcification is an increasingly recognized cause, particularly in an aging population. Echocardiography plays a primary role in imaging mitral stenosis with a growing role for cardiac computed tomography and magnetic resonance imaging. In this review, we aim to revisit mitral stenosis assessment and quantification using multimodality imaging. Recent findings There is an increasing role for advanced cardiac imaging especially in the era of transcatheter mitral valve intervention. Also, when echocardiography is suboptimal or discordant with symptoms, computed tomography can provide anatomical data, whereas magnetic resonance imaging can provide anatomical along with hemodynamic data. Summary Diagnosis of mitral stenosis is crucial as it carries an increased morbidity and mortality risk. Echocardiography is the cornerstone imaging modality with alternative, complementary advanced imaging considered when images are suboptimal.
- 2 January 2020
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 27 (6) , 2412-2416
Positrons, protons, and pulse waves: Multimodality characterization of newly diagnosed hypertrophic cardiomyopathy
- 2 January 2020
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 27 (6) , 2412-2416
Positrons, protons, and pulse waves: Multimodality characterization of newly diagnosed hypertrophic cardiomyopathy
- 1 January 2020
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 16 (1) , 65-67
A T2-Weighty Discovery: Aortitis on Cardiac MRI with Histopathologic Correlation
- 1 January 2020
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 16 (1) , 65-67
A T2-Weighty Discovery: Aortitis on Cardiac MRI with Histopathologic Correlation
- 1 September 2019
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 34 (5) , 502-509
Assessment of myocardial viability by cardiac MRI
Purpose of review Left ventricular systolic dysfunction because of coronary artery disease is common, and ascertaining which patients will benefit from revascularization can be challenging. Viability testing is an accepted means by which to base this decision, with multiple noninvasive imaging modalities available for this purpose. This review aims to highlight the key role of cardiac magnetic resonance in myocardial viability assessment, with a focus on its unique strengths over other imaging modalities. Recent findings Transmural extent of hyperenhancement with late gadolinium imaging has been shown to be greater acutely in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and regress at follow-up studies. An explanation for this reported phenomenon and an argument against redefining CMR viability criteria in the acute setting will be offered. Summary Although not universally available, cardiac magnetic resonance is an exceptionally powerful and well tolerated imaging modality that should be considered when viability testing will influence patient management. Although observational outcomes data suggest a promising prognostic role for viability, randomized studies in this area are needed.
- 1 September 2019
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 34 (5) , 502-509
Assessment of myocardial viability by cardiac MRI
Purpose of review Left ventricular systolic dysfunction because of coronary artery disease is common, and ascertaining which patients will benefit from revascularization can be challenging. Viability testing is an accepted means by which to base this decision, with multiple noninvasive imaging modalities available for this purpose. This review aims to highlight the key role of cardiac magnetic resonance in myocardial viability assessment, with a focus on its unique strengths over other imaging modalities. Recent findings Transmural extent of hyperenhancement with late gadolinium imaging has been shown to be greater acutely in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and regress at follow-up studies. An explanation for this reported phenomenon and an argument against redefining CMR viability criteria in the acute setting will be offered. Summary Although not universally available, cardiac magnetic resonance is an exceptionally powerful and well tolerated imaging modality that should be considered when viability testing will influence patient management. Although observational outcomes data suggest a promising prognostic role for viability, randomized studies in this area are needed.
- Open Access
- 1 June 2019
- Published by Elsevier in JACC: Case Reports
- Vol. 1 (1) , 64-66
Between a Rock and a Hard Place
- 1 June 2019
- Published by Elsevier in JACC: Case Reports
- Vol. 1 (1) , 64-66
Open AccessBetween a Rock and a Hard Place
- Open Access
- 11 April 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (4) , e230038
Hypertrophic cardiomyopathy with mid-cavitary obstruction and apical aneurysm thrombus after transapical myectomy and aneurysmectomy
A 58-year-old woman with known hypertrophic cardiomyopathy (HCM) was hospitalised for recurrent, intractable heart failure despite guideline-directed medical therapy. Her HCM phenotype was concentric with mid-cavitary obstruction (MCO) and an associated large apical aneurysm. Her cardiac history included resuscitated sudden cardiac arrest with subsequent implantable cardioverter-defibrillator (ICD), and ventricular tachycardia (VT) endocardial and epicardial ablation for appropriate ICD shocks during VT storm.
- 11 April 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (4) , e230038
Open AccessHypertrophic cardiomyopathy with mid-cavitary obstruction and apical aneurysm thrombus after transapical myectomy and aneurysmectomy
A 58-year-old woman with known hypertrophic cardiomyopathy (HCM) was hospitalised for recurrent, intractable heart failure despite guideline-directed medical therapy. Her HCM phenotype was concentric with mid-cavitary obstruction (MCO) and an associated large apical aneurysm. Her cardiac history included resuscitated sudden cardiac arrest with subsequent implantable cardioverter-defibrillator (ICD), and ventricular tachycardia (VT) endocardial and epicardial ablation for appropriate ICD shocks during VT storm.
- 1 April 2019
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 15 (2) , 156-157
Do I Look Fat in This? Multimodality Imaging Findings of a Cardiac Lipoma
- 1 April 2019
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 15 (2) , 156-157
Do I Look Fat in This? Multimodality Imaging Findings of a Cardiac Lipoma
- 11 February 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 158 (1) , e1-e4
Lightning striking twice: Redo mitral valve replacement due to recurrent cardiac sarcoma using partial autotransplantation technique
- 11 February 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 158 (1) , e1-e4
Lightning striking twice: Redo mitral valve replacement due to recurrent cardiac sarcoma using partial autotransplantation technique
- Open Access
- 1 March 2018
- Published by Wiley in Pulmonary Circulation
- Vol. 8 (2) , 1-5
A case of ruptured sinus of Valsalva aneurysm and reversible flow‐induced pulmonary hypertension
Pulmonary hypertension (PH) in adults with congenital heart disease (CHD) and significant systemic‐to‐pulmonary shunting is a significant cause of morbidity and mortality. Its pathophysiology is incompletely understood, but involves a flow‐induced pulmonary arteriopathy characterized by endothelial cell dysfunction and vascular remodeling that alters pulmonary arterial vasoreactivity. There is a paucity of literature linking PH with left‐to‐right shunting due to ruptured sinus of Valsalva aneurysms (SOVA). We present a unique case of reversible, flow‐associated PH due to a ruptured congenital right SOVA fistulizing into the right atrium (RA), with emphasis on non‐invasive and invasive assessment of pulmonary hemodynamics before and after surgical intervention.
- 1 March 2018
- Published by Wiley in Pulmonary Circulation
- Vol. 8 (2) , 1-5
Open AccessA case of ruptured sinus of Valsalva aneurysm and reversible flow‐induced pulmonary hypertension
Pulmonary hypertension (PH) in adults with congenital heart disease (CHD) and significant systemic‐to‐pulmonary shunting is a significant cause of morbidity and mortality. Its pathophysiology is incompletely understood, but involves a flow‐induced pulmonary arteriopathy characterized by endothelial cell dysfunction and vascular remodeling that alters pulmonary arterial vasoreactivity. There is a paucity of literature linking PH with left‐to‐right shunting due to ruptured sinus of Valsalva aneurysms (SOVA). We present a unique case of reversible, flow‐associated PH due to a ruptured congenital right SOVA fistulizing into the right atrium (RA), with emphasis on non‐invasive and invasive assessment of pulmonary hemodynamics before and after surgical intervention.